BJS: 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide
BJS is a Ligand Of Interest in 5QCH designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 5QCH_BJS_B_803 | 74% | 59% | 0.102 | 0.935 | 0.79 | 0.64 | 2 | 1 | 0 | 0 | 100% | 0.92 |
| 5QCH_BJS_C_802 | 72% | 60% | 0.106 | 0.933 | 0.77 | 0.63 | 1 | 1 | 0 | 0 | 100% | 0.92 |
| 5QCH_BJS_D_803 | 68% | 57% | 0.112 | 0.926 | 0.86 | 0.64 | 2 | 1 | 0 | 0 | 100% | 0.92 |
| 5QCH_BJS_A_802 | 67% | 60% | 0.11 | 0.918 | 0.77 | 0.63 | 2 | 1 | 0 | 0 | 100% | 0.92 |